Anlotinib and Irinotecan for Ewing Sarcoma

Clinical trial NCT03416517 · UNKNOWN

Trial details

NCT number: NCT03416517
Sponsor: Peking University People's Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ewing's Tumor Metastatic

Start date: 2018-01-22
Primary completion: 2020-02-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.